scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1005493321 |
P356 | DOI | 10.1038/SJ.ONC.1209967 |
P3181 | OpenCitations bibliographic resource ID | 4736415 |
P698 | PubMed publication ID | 16964284 |
P5875 | ResearchGate publication ID | 6826915 |
P2093 | author name string | C L Bevan | |
Y Kawano | |||
S M Powell | |||
D Chotai | |||
J Waxman | |||
D A Dart | |||
S C Gamble | |||
V Reebye | |||
A Varela-Carver | |||
G N Brooke | |||
M Odontiadis | |||
P2860 | cites work | An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens | Q22009952 |
Prohibitin Induces the Transcriptional Activity of p53 and Is Exported from the Nucleus upon Apoptotic Signaling | Q24294918 | ||
Prohibitin co-localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repression | Q24323389 | ||
Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor | Q24532913 | ||
Human checkpoint protein hRad9 functions as a negative coregulator to repress androgen receptor transactivation in prostate cancer cells | Q24607572 | ||
Recognition and accommodation at the androgen receptor coactivator binding interface | Q24799399 | ||
High-efficiency transformation of mammalian cells by plasmid DNA | Q27860469 | ||
Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteins. | Q27934000 | ||
Prohibitins regulate membrane protein degradation by the m-AAA protease in mitochondria | Q27934696 | ||
The prohibitin family of mitochondrial proteins regulate replicative lifespan | Q27940160 | ||
Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function | Q28137829 | ||
A putative coiled-coil domain of prohibitin is sufficient to repress E2F1-mediated transcription and induce apoptosis | Q28187292 | ||
The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT | Q28239712 | ||
The nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor | Q28263578 | ||
Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter | Q29616537 | ||
The role of coactivators in steroid hormone action. | Q33786844 | ||
Transcriptional repression by nuclear hormone receptors | Q33826663 | ||
Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor | Q33978884 | ||
Retinoblastoma, a tumor suppressor, is a coactivator for the androgen receptor in human prostate cancer DU145 cells. | Q34067036 | ||
Bicalutamide functions as an androgen receptor antagonist by assembly of a transcriptionally inactive receptor | Q34128784 | ||
BRG1/BRM and prohibitin are required for growth suppression by estrogen antagonists | Q34348559 | ||
Nuclear receptors: a rendezvous for chromatin remodeling factors | Q35197820 | ||
Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes | Q35974510 | ||
Isolation and characterization of complementary DNAs encoding human manganese-containing superoxide dismutase | Q36312887 | ||
Prohibitin, an evolutionarily conserved intracellular protein that blocks DNA synthesis in normal fibroblasts and HeLa cells | Q36958660 | ||
Analysis of estrogen receptor interaction with a repressor of estrogen receptor activity (REA) and the regulation of estrogen receptor transcriptional activity by REA. | Q38308965 | ||
Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration | Q40393756 | ||
Cyclin D1 binding to the androgen receptor (AR) NH2-terminal domain inhibits activation function 2 association and reveals dual roles for AR corepression | Q40493146 | ||
Androgen receptor is targeted to distinct subcellular compartments in response to different therapeutic antiandrogens | Q40494172 | ||
Androgens target prohibitin to regulate proliferation of prostate cancer cells. | Q40589151 | ||
Differential modulation of androgen receptor transcriptional activity by the nuclear receptor co-repressor (N-CoR). | Q40595558 | ||
Differential regulation of Rb family proteins and prohibitin during camptothecin-induced apoptosis | Q40722121 | ||
Formation of the androgen receptor transcription complex | Q40740525 | ||
Characterization of prohibitin in a newly established rat ovarian granulosa cell line | Q40784641 | ||
A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor | Q41051243 | ||
Isolation of a cDNA that hybrid selects antiproliferative mRNA from rat liver | Q44924689 | ||
A pp32-retinoblastoma protein complex modulates androgen receptor-mediated transcription and associates with components of the splicing machinery | Q46594615 | ||
Synthetic progestins induce proliferation of breast tumor cell lines via the progesterone or estrogen receptor. | Q52216577 | ||
Change of specificity mutations in androgen-selective enhancers. Evidence for a role of differential DNA binding by the androgen receptor. | Q53993571 | ||
The human androgen receptor: domain structure, genomic organization and regulation of expression. | Q54116950 | ||
Inhibition of the Dihydrotestosterone-Activated Androgen Receptor by Nuclear Receptor Corepressor | Q55884170 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Prohibitin | Q2112279 |
negative regulation of glucocorticoid receptor signaling pathway | Q21109584 | ||
P304 | page(s) | 1757-68 | |
P577 | publication date | 2007-03-15 | |
P1433 | published in | Oncogene | Q1568657 |
P1476 | title | Prohibitin, a protein downregulated by androgens, represses androgen receptor activity | |
P478 | volume | 26 |
Q33557664 | A novel role for GSK3β as a modulator of Drosha microprocessor activity and MicroRNA biogenesis |
Q36447412 | A repressive role for prohibitin in estrogen signaling. |
Q33830761 | Aberrant expression of nuclear matrix proteins during HMBA-induced differentiation of gastric cancer cells |
Q26740628 | Advances in genetics: widening our understanding of prostate cancer |
Q34943321 | Androgen Receptor regulation of Vitamin D receptor in response of castration-resistant prostate cancer cells to 1α-Hydroxyvitamin D5 - a calcitriol analog |
Q36734752 | Androgen receptor and prostate cancer |
Q38314940 | Androgen receptor epigenetics. |
Q36961208 | Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis |
Q33922393 | Androgen receptor functions in prostate cancer development and progression |
Q91676732 | Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer |
Q38326097 | Androgen-regulated processing of the oncomir miR-27a, which targets Prohibitin in prostate cancer. |
Q38908290 | Antiandrogens act as selective androgen receptor modulators at the proteome level in prostate cancer cells. |
Q38866849 | Effect of estrogen on expression of prohibitin in white adipose tissue and liver of diet-induced obese rats |
Q30428062 | Estrogen-regulated prohibitin is required for mouse uterine development and adult function. |
Q58696754 | Gonadectomy in Mito-Ob mice revealed a sex-dimorphic relationship between prohibitin and sex steroids in adipose tissue biology and glucose homeostasis |
Q28972422 | Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours |
Q46882539 | Mechanisms of androgen receptor activation in advanced prostate cancer: differential co-activator recruitment and gene expression. |
Q37034181 | Nuclear receptor co-regulator Krüppel-like factor 9 and prohibitin 2 expression in estrogen-induced epithelial cell proliferation in the mouse uterus |
Q34157750 | Preliminary quantitative profile of differential protein expression between rat L6 myoblasts and myotubes by stable isotope labeling with amino acids in cell culture |
Q38288384 | Prohibitin - At the crossroads of obesity-linked diabetes and cancer. |
Q24314424 | Prohibitin and the SWI/SNF ATPase subunit BRG1 are required for effective androgen antagonist-mediated transcriptional repression of androgen receptor-regulated genes |
Q39657252 | Prohibitin is a cholesterol‐sensitive regulator of cell cycle transit |
Q37728643 | Prohibitin is required for transcriptional repression by the WT1-BASP1 complex. |
Q38092225 | Prohibitin ligands in cell death and survival: mode of action and therapeutic potential |
Q35737753 | Prohibitin silencing reverses stabilization of mitochondrial integrity and chemoresistance in ovarian cancer cells by increasing their sensitivity to apoptosis |
Q36829123 | Prohibitin( PHB) roles in granulosa cell physiology |
Q64275992 | Prohibitin: a prime candidate for a pleiotropic effector that mediates sex differences in obesity, insulin resistance, and metabolic dysregulation |
Q36187056 | Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens |
Q24298419 | Repression of androgen receptor activity by HEYL, a third member of the Hairy/Enhancer-of-split-related family of Notch effectors |
Q34497715 | Roles of prohibitin in growth control and tumor suppression in human cancers |
Q38074717 | Signaling pathways of prohibitin and its role in diseases |
Q41893749 | Skp2 and Skp2B team up against Rb and p53. |
Q33383797 | TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer. |
Q64910810 | The novel long noncoding RNA LOC283070 is involved in the transition of LNCaP cells into androgen-independent cells via its interaction with PHB2. |
Q42371544 | The prohibitin protein complex promotes mitochondrial stabilization and cell survival in hematologic malignancies |
Q38433570 | The prohibitin-repressive interaction with E2F1 is rapidly inhibited by androgen signalling in prostate cancer cells |
Search more.